Form 4: Eli Lilly Director Gabrielle Sulzberger Acquires Shares Through Deferred Compensation Plan

Eli Lilly & Co. Director Gabrielle Sulzberger acquired additional common stock through a deferred compensation arrangement, increasing her beneficial ownership.

Summary

• Gabrielle Sulzberger, a Director at Eli Lilly & Co (LLY), acquired 6.505 shares of common stock.
• The transaction occurred on July 21, 2025, with shares valued at $762.18 per share.
• The shares were acquired as part of the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• These stock units will be settled in shares of common stock following Ms. Sulzberger's separation from service.
• Following this transaction, Ms. Sulzberger's direct beneficial ownership of Eli Lilly & Co common stock stands at 2,586.055 shares.

Sentiment

Score: 6

Explanation: Slightly positive, as a director is increasing their stake in the company, albeit through a compensation plan, which generally signals confidence and aligns interests with shareholders.

Positives

• Director Gabrielle Sulzberger increased her beneficial ownership in Eli Lilly & Co, aligning her interests further with shareholders.
• The transaction is part of a structured deferred compensation plan, indicating a standard and pre-planned compensation mechanism for directors.

Future Outlook

The acquired shares, deferred as stock units, will be settled in common stock following the reporting person's separation from service, indicating a future conversion event.

Management Comments

• The shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This transaction represents a routine compensation event for a director within a major pharmaceutical company, consistent with common corporate governance practices where non-executive directors receive a portion of their compensation in company equity to align their interests with shareholders.

Corporate Governance

Related Party Transactions

• Acquisition of common stock by a director (Gabrielle Sulzberger) from the company as part of a deferred compensation plan, which is a standard related-party transaction for director remuneration.

Stakeholder Impact

• Shareholders: Increased alignment of director interests with shareholder value due to increased equity ownership.
• Employees: No direct impact mentioned.

Next Steps

• Settlement of the deferred stock units into common stock upon Gabrielle Sulzberger's separation from service.

Key Dates

Keywords

Eli Lilly, LLY, Form 4, Insider Trading, Director Compensation, Stock Acquisition, Deferred Compensation, Pharmaceuticals, Biotechnology